Clinical Trials · NCT01971242

Trial of Exenatide for Parkinson's Disease

Name: Trial of Exenatide for Parkinson's Disease
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Exenatide

Phase: Phase 2
Recruitment status: Completed
Sponsor: University College, London
Enrollment: 60
Start date: Jun 2014
Locations: 1 site, United Kingdom
Primary endpoint: Efficacy

View Exenatide compound reference